Journal of Clinical Endocrinology & Metabolism, Vol 77, 600-604, Copyright © 1993 by Endocrine Society

ARTICLES

Glu-47, which forms a salt bridge between neurophysin-II and arginine vasopressin, is deleted in patients with familial central diabetes insipidus

H Yuasa, M Ito, H Nagasaki, Y Oiso, S Miyamoto, N Sasaki and H Saito
First Department of Internal Medicine, Nagoya University School of Medicine, Aichi, Japan.

The arginine vasopressin (AVP) gene was sequenced in a pedigree with familial central diabetes insipidus (DI). When polymerase chain reaction-amplified DNAs from affected subjects were subjected to polyacrylamide gel electrophoresis, fragments including exon 2 displayed two additional, slower migrating bands. These extra bands represented DNA heteroduplexes, indicating that there was a deletion or insertion mutation in exon 2. As the region with such a mutation was identified by direct sequence analysis, polymerase chain reaction- amplified fragments including the region were subcloned and sequenced. A 3-basepair deletion (AGG) out of two consecutive AGG sequences (nucleotides 1824-1829) was identified in one of two alleles. The cosegregation of the mutation with the DI phenotype in the family was confirmed by restriction enzyme analyses. This mutation should yield an abnormal AVP precursor lacking Glu47 in its neurophysin-II (NP) moiety. Since Glu47 is essential for NP molecules to form a salt bridge with AVP, it is very likely that the function of NP as a carrier protein for AVP would be impaired. We suggest that AVP would undergo accelerated proteolytic degradation, and this mechanism would be involved in the pathogenesis of DI in this pedigree.

This article has been cited by other articles:

				Y.-W. Lee, K. W. Lee, J. W. Ryu, J. O. Mok, C.-S. Ki, H. K. Park, Y. J. Kim, S. J. Kim, D. W. Byun, K. I. Suh, et al. Mutation of Glu78 of the AVP-NPII Gene Impairs Neurophysin as a Carrier Protein for Arginine Vasopressin in a Family with Neurohypophyseal Diabetes Insipidus Ann. Clin. Lab. Sci., January 1, 2008; 38(1): 12 - 14. [Abstract] [Full Text] [PDF]

				L. Ye, X. Li, Y. Chen, H. Sun, W. Wang, T. Su, L. Jiang, B. Cui, and G. Ning Autosomal Dominant Neurohypophyseal Diabetes Insipidus with Linkage to Chromosome 20p13 but without Mutations in the AVP-NPII Gene J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4388 - 4393. [Abstract] [Full Text] [PDF]

				C. P. Mahoney, E. Weinberger, C. Bryant, M. Ito, J. L. Jameson, and M. Ito Effects of Aging on Vasopressin Production in a Kindred with Autosomal Dominant Neurohypophyseal Diabetes Insipidus Due to the {Delta}E47 Neurophysin Mutation J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 870 - 876. [Abstract] [Full Text] [PDF]

				A. P. Abbes, B. Bruggeman, E. L.T. van den Akker, M. R. de Groot, A. A.M. Franken, V. R. Drexhage, and H. Engel Identification of Two Distinct Mutations at the Same Nucleotide Position, Concomitantly with a Novel Polymorphism in the Vasopressin-Neurophysin II Gene (AVP-NP II) in Two Dutch Families with Familial Neurohypophyseal Diabetes Insipidus Clin. Chem., October 1, 2000; 46(10): 1699 - 1702. [Full Text] [PDF]

				B. Calvo, J. R. Bilbao, A. Rodríguez, M. D. Rodríguez-Arnao, and L. Castaño Molecular Analysis in Familial Neurohypophyseal Diabetes Insipidus: Early Diagnosis of an Asymptomatic Carrier J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3351 - 3354. [Abstract] [Full Text]

				C. Siggaard, S. Rittig, T. J. Corydon, P. H. Andreasen, T. G. Jensen, B. S. Andresen, G. L. Robertson, N. Gregersen, L. Bolund, and E. B. Pedersen Clinical and Molecular Evidence of Abnormal Processing and Trafficking of the Vasopressin Preprohormone in a Large Kindred with Familial Neurohypophyseal Diabetes Insipidus due to A Signal Peptide Mutation J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2933 - 2941. [Abstract] [Full Text]

				M. Ito, R. N. Yu, J. L. Jameson, and M. Ito Mutant Vasopressin Precursors That Cause Autosomal Dominant Neurohypophyseal Diabetes Insipidus Retain Dimerization and Impair the Secretion of Wild-type Proteins J. Biol. Chem., March 26, 1999; 274(13): 9029 - 9037. [Abstract] [Full Text] [PDF]

				F. D. Grant, A. Ahmadi, C. M. Hosley, and J. A. Majzoub Two Novel Mutations of the Vasopressin Gene Associated with Familial Diabetes Insipidus and Identification of an Asymptomatic Carrier Infant J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 3958 - 3964. [Abstract] [Full Text]

				B. Calvo, J. R. Bilbao, I. Urrutia, J. Eizaguirre, S. Gaztambide, and L. Castaño Identification of a Novel Nonsense Mutation and a Missense Substitution in the Vasopressin-Neurophysin II Gene in Two Spanish Kindreds with Familial Neurohypophyseal Diabetes Insipidus J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 995 - 997. [Abstract] [Full Text]

				P. C. Gagliardi, S. Bernasconi, and D. R. Repaske Autosomal Dominant Neurohypophyseal Diabetes Insipidus Associated with a Missense Mutation Encoding Gly23->Val in Neurophysin II J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3643 - 3646. [Abstract] [Full Text] [PDF]

				D. R. Repaske, R. Medlej, E. K. Gultekin, M. R. S. Krishnamani, G. Halaby, J. W. Findling, and J. A. Phillips III Heterogeneity in Clinical Manifestation of Autosomal Dominant Neurohypophyseal Diabetes Insipidus Caused by a Mutation Encoding Ala-1->Val in the Signal Peptide of the Arginine Vasopressin/Neurophysin II/Copeptin Precursor J. Clin. Endocrinol. Metab., January 1, 1997; 82(1): 51 - 56. [Abstract] [Full Text] [PDF]